Michael Mingzhao Xing

Professor

1992 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Thyroid Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Thyroid Gland Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Methylation Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer

Wang, F. , Zhao, S. , Shen, X. , Zhu, G. , Liu, R. , Viola, D. , Elisei, R. , Puxeddu, E. , Fugazzola, L. , Colombo, C. , Jarzab, B. , Czarniecka, A. , Lam, A. K. , Mian, C. , Vianello, F. , Yip, L. , Riesco-Eizaguirre, G. , Santisteban, P. , O’Neill, C. J. , Sywak, M. S. & 5 others Clifton-Bligh, R., Bendlova, B., Sýkorová, V., Wang, Y. & Xing, M., Sep 20 2018, In : Journal of Clinical Oncology. 36, 27, p. 2787-2795 9 p.

Research output: Contribution to journalArticle

Mortality
Papillary Thyroid cancer
Neoplasm Metastasis

BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment

Huang, Y. , Qu, S. , Zhu, G. , Wang, F. , Liu, R. , Shen, X. , Viola, D. , Elisei, R. , Puxeddu, E. , Fugazzola, L. , Colombo, C. , Jarzab, B. , Czarniecka, A. , Lam, A. K. , Mian, C. , Vianello, F. , Yip, L. , Riesco-Eizaguirre, G. , Santisteban, P. , O'Neill, C. J. & 1 others Xing, M., Apr 1 2018, In : Journal of the National Cancer Institute. 110, 4

Research output: Contribution to journalArticle

Mutation
Recurrence
Confidence Intervals
Therapeutics
Factor IX

Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer

Shen, X. , Zhu, G. , Liu, R. , Viola, D. , Elisei, R. , Puxeddu, E. , Fugazzola, L. , Colombo, C. , Jarzab, B. , Czarniecka, A. , Lam, A. K. , Mian, C. , Vianello, F. , Yip, L. , Riesco-Eizaguirre, G. , Santisteban, P. , ONeill, C. J. , Sywak, M. S. , Clifton-Bligh, R. , Bendlova, B. & 2 others Sykorova, V. & Xing, M., Feb 10 2018, In : Journal of Clinical Oncology. 36, 5, p. 438-445 8 p.

Research output: Contribution to journalArticle

Mortality
Papillary Thyroid cancer
Mutation
Risk Management
Kaplan-Meier Estimate

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

Liu, R., Zhang, T., Zhu, G. & Xing, M., Dec 1 2018, In : Nature Communications. 9, 1, 579

Research output: Contribution to journalArticle

oncogenes
Phosphotransferases
cancer
Oncogene Proteins
Oncogenes

Reply to M. Melo et al

Shen, X. & Xing, M., May 10 2018, In : Journal of Clinical Oncology. 36, 14, p. 1457-1458 2 p.

Research output: Contribution to journalLetter